Alivus Life

70
Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
1,090.45
42.45 (4.05%)
BSENSE

May 26

BSE+NSE Vol: 1.39 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.54% vs 5.64% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 1.24% vs 4.97% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 56.14% vs 182.63% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 3.13% vs 0.84% in Mar 2024

Compare Profit and Loss Results of Alivus Life
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,386.00
6,032.00
-3,646.00
-60.44%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,386.00
6,032.00
-3,646.00
-60.44%
Expenditure (Ex Depriciation)
Stock Adjustments
27.00
-268.00
295.00
110.07%
Raw Materials Consumed
1,053.00
2,057.00
-1,004.00
-48.81%
Power & Fuel Cost
117.00
179.00
-62.00
-34.64%
Employee Cost
251.00
1,466.00
-1,215.00
-82.88%
Operating Expenses
134.00
388.00
-254.00
-65.46%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
53.00
724.00
-671.00
-92.68%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
36.00
38.00
-2.00
-5.26%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,704.00
5,131.00
-3,427.00
-66.79%
Operating Profit (PBDIT) excl Other Income
682.00
901.00
-219.00
-24.31%
Other Income
34.00
47.00
-13.00
-27.66%
Operating Profit (PBDIT)
717.00
949.00
-232.00
-24.45%
Interest
2.00
76.00
-74.00
-97.37%
Profit before Depriciation and Tax
714.00
872.00
-158.00
-18.12%
Depreciation
60.00
277.00
-217.00
-78.34%
Profit Before Taxation & Exceptional Items
654.00
595.00
59.00
9.92%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
654.00
608.00
46.00
7.57%
Provision for Tax
168.00
105.00
63.00
60.00%
Profit After Tax
485.00
503.00
-18.00
-3.58%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,291.00
4,160.00
-2,869.00
-68.97%
Profit Available for appropriations
1,777.00
4,664.00
-2,887.00
-61.90%
Appropriations
1,777.00
4,664.00
-2,887.00
-61.90%
Equity Dividend (%)
250%
550%
-300.00
Earnings Per Share
39.63
25.6
14.03
54.80%
Profit And Loss - Net Sales
Net Sales 2,386.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.54% vs 5.64% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 682.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.24% vs 4.97% in Mar 2024

Profit And Loss - Interest
Interest 2.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 56.14% vs 182.63% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 485.63 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 3.13% vs 0.84% in Mar 2024